Skip to main content
Premium Trial:

Request an Annual Quote

Netherlands Provides $18M for New Proteomics Facility

NEW YORK (GenomeWeb News) – The Netherlands has pumped €13.5 million ($17.9 million) into a new proteomics research facility that will support research and foster collaboration with partners at several major Dutch life sciences institutes, according to Utrecht University.

Funded by the Netherlands Organization for Scientific Research, the [email protected] facility will provide technologies, equipment, and expertise for proteomics and protein interaction research throughout the country.

The large-scale proteomics facility will consist of a core hub facility at Utrecht University, with smaller labs at the Netherlands Cancer Institute, the Erasmus Medical Centre Rotterdam, and the University Medical Centre in Utrecht.

The facility, which will build upon the resources provided by the Netherlands Proteomics Centre and the Prime-XS proteomics facility, will provide open access to life scientists at universities and hospitals and in industry.

"We work with everybody who wants to understand how proteins work, for example how proteins can cause disease, but also how stem cells can develop into healthy organs," Albert Heck, scientific director of the Netherlands Proteomics Centre and initiator of [email protected], said in a statement.

Concurrent with the funding announcement for the [email protected] facility, the University of Utrecht also said that the Netherlands Organization for Scientific Research has awarded €18.5 million for a nuclear magnetic resonance and MRI imaging facility to study Alzheimer's and Parkinson's diseases and for drug development and agricultural research that will be a partnership between Utrecht University and several other Dutch universities.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.